Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antibody”

7,886 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 7,886 results

Not applicableUnknownNCT02852850
What this trial is testing

In Vivo Molecular Imaging Predicts Therapeutic Response in Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Shandong University 30
Early research (Phase 1)Study completedNCT00076180
What this trial is testing

Hu-Mik-beta1 to Treat T-Cell Large Granular Lymphocytic Leukemia

Who this might be right for
T-Cell Large Granular Lymphocytic LeukemiaLeukemia, T-Cell Large Granular Lymphocytic
National Cancer Institute (NCI) 9
Not applicableUnknownNCT04339127
What this trial is testing

Autoimmune Encephalitis With Anti-NMDA Receptor Antibodies Following Herpetic Encephalitis

Who this might be right for
Autoimmune EncephalitisAnti NMDA Receptor EncephalitisHerpetic Encephalitis
Hospices Civils de Lyon 12
Early research (Phase 1)Ended earlyNCT00351325
What this trial is testing

BMS-663513 Administered in Combination With Chemotherapy to Subjects With Advanced Solid Malignancies

Who this might be right for
Advanced Solid Malignancies
Bristol-Myers Squibb 45
Not applicableActive Not RecruitingNCT06767020
What this trial is testing

Comparative Study on AQP4 Antibody Detection Methods

Who this might be right for
NMOSD
First Affiliated Hospital of Chongqing Medical University 120
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07419880
What this trial is testing

Re-challenge Immunotherapy With Cromolyn, TQB2102, and Panpulimab in Immune-Refractory Triple Negative Breast Cancer

Who this might be right for
Triple -Negative Breast Cancer
Fudan University 46
Post-approval studies (Phase 4)Active Not RecruitingNCT07274462
What this trial is testing

DARA-MVI Study (Daratumumab for Microvascular Inflammation in Kidney Transplantation)

Who this might be right for
Microvascular Inflammation - MVI in Kindey Transplant Recipients
University Hospital, Martin 20
Not applicableStudy completedNCT00267826
What this trial is testing

Immunopharmacological Effects of Rituximab in Atopic Dermatitis

Who this might be right for
Dermatitis, Atopic
University of Bern 6
Not applicableUnknownNCT04664647
What this trial is testing

The Clinical Features of Combined Central and Peripheral Demyelination

Who this might be right for
Combined Central and Peripheral Demyelination Disease
Xuanwu Hospital, Beijing 30
Testing effectiveness (Phase 2)Study completedNCT00904826
What this trial is testing

An Open Label Study of the Effects of Eculizumab in Neuromyelitis Optica

Who this might be right for
Neuromyelitis OpticaDevic's Disease
Mayo Clinic 14
Testing effectiveness (Phase 2)Study completedNCT00048555
What this trial is testing

Safety and Efficacy of IDEC-114 in Combination With Rituxan in the Treatment of Non-Hodgkin's Lymphoma

Who this might be right for
Non-Hodgkin's Lymphoma
Biogen 90
Not applicableEnded earlyNCT00582608
What this trial is testing

Tumor Detection Using Iodine-131-Labeled Monoclonal Antibody 8H9

Who this might be right for
CNS CancerNeuroblastomaSarcoma
Memorial Sloan Kettering Cancer Center 12
Not applicableUnknownNCT04563650
What this trial is testing

COVID-19 Serology and Immunosenescence

Who this might be right for
Covid19Geriatric MedicineSeroconversion+1 more
Centre Hospitalier Universitaire, Amiens 98
Testing effectiveness (Phase 2)Study completedNCT04667910
What this trial is testing

601 Versus Ranibizumab in Patients With Central Retinal Vein Occlusion (CRVO)

Who this might be right for
Central Retinal Vein Occlusion
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. 60
Not applicableStudy completedNCT03728062
What this trial is testing

Mindfulness Meditation Versus Physical Exercise: Comparing Effects on Stress and Immunocompetence

Who this might be right for
StressHealth Knowledge, Attitudes, Practice
Universidad Nacional de Educación a Distancia 72
Early research (Phase 1)Study completedNCT03744403
What this trial is testing

CS1001 in Subjects with Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
CStone Pharmaceuticals 24
Testing effectiveness (Phase 2)Study completedNCT00924170
What this trial is testing

Phase II Trial of LMB-2, Fludarabine and Cyclophosphamide for Adult T-Cell Leukemia

Who this might be right for
Adult T-Cell Leukemia (ATL)
National Cancer Institute (NCI) 18
Testing effectiveness (Phase 2)Study completedNCT01016015
What this trial is testing

Temsirolimus and Cixutumumab in Treating Patients With Locally Advanced, Metastatic, or Recurrent Soft Tissue Sarcoma or Bone Sarcoma

Who this might be right for
Metastatic OsteosarcomaRecurrent Adult Soft Tissue SarcomaRecurrent Osteosarcoma+2 more
National Cancer Institute (NCI) 178
Testing effectiveness (Phase 2)WithdrawnNCT03575208
What this trial is testing

Hepatitis B Immune Globulin (HBIg) to Restore Immune Control in People With Chronic Hepatitis B

Who this might be right for
Chronic Hepatitis B
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Large-scale testing (Phase 3)Study completedNCT00049517
What this trial is testing

Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With AML Leukemia

Who this might be right for
Leukemia
Eastern Cooperative Oncology Group 657
Load More Results